Variant report
Variant | nsv970129 |
---|---|
Chromosome Location | chr6:58214732-58243303 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:55)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr6:58225246-58225574 | GM12878 | blood: | n/a | n/a |
2 | ATF2 | chr6:58226933-58227385 | GM12878 | blood: | n/a | n/a |
3 | ATF2 | chr6:58226948-58227297 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr6:58241686-58241892 | GM12878 | blood: | n/a | chr6:58241758-58241769 |
5 | BATF | chr6:58225176-58225639 | GM12878 | blood: | n/a | n/a |
6 | BATF | chr6:58241206-58241440 | GM12878 | blood: | n/a | chr6:58241313-58241322 chr6:58241337-58241348 |
7 | BATF | chr6:58226995-58227530 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr6:58241654-58241917 | GM12878 | blood: | n/a | chr6:58241758-58241769 |
9 | BATF | chr6:58225149-58225723 | GM12878 | blood: | n/a | n/a |
10 | BATF | chr6:58226989-58227547 | GM12878 | blood: | n/a | n/a |
11 | BCL11A | chr6:58227066-58227268 | GM12878 | blood: | n/a | n/a |
12 | BCL11A | chr6:58226962-58227383 | GM12878 | blood: | n/a | n/a |
13 | BCL11A | chr6:58225136-58225637 | GM12878 | blood: | n/a | n/a |
14 | CTCF | chr6:58216143-58216282 | GM13976 | blood: | n/a | n/a |
15 | CTCF | chr6:58231641-58231711 | GM20000 | blood: | n/a | n/a |
16 | CTCF | chr6:58238089-58238128 | GM10248 | blood: | n/a | n/a |
17 | CTCF | chr6:58230914-58230995 | GM20000 | blood: | n/a | n/a |
18 | CTCF | chr6:58220508-58220531 | GM20000 | blood: | n/a | n/a |
19 | CTCF | chr6:58240294-58240337 | Kidney_OC | kidney: | n/a | n/a |
20 | CTCF | chr6:58232546-58232593 | GM10266 | blood: | n/a | n/a |
21 | EP300 | chr6:58227043-58227281 | GM12878 | blood: | n/a | n/a |
22 | FOXA1 | chr6:58230632-58230889 | HepG2 | liver: | n/a | n/a |
23 | FOXM1 | chr6:58225036-58225638 | GM12878 | blood: | n/a | chr6:58225439-58225447 |
24 | FOXM1 | chr6:58226933-58227397 | GM12878 | blood: | n/a | n/a |
25 | GATA2 | chr6:58230659-58230813 | SH-SY5Y | brain: | n/a | n/a |
26 | IRF4 | chr6:58225102-58225654 | GM12878 | blood: | n/a | n/a |
27 | IRF4 | chr6:58226983-58227339 | GM12878 | blood: | n/a | n/a |
28 | IRF4 | chr6:58225138-58225663 | GM12878 | blood: | n/a | n/a |
29 | IRF4 | chr6:58226950-58227413 | GM12878 | blood: | n/a | n/a |
30 | JUND | chr6:58237676-58237859 | HepG2 | liver: | n/a | n/a |
31 | MEF2A | chr6:58225125-58225706 | GM12878 | blood: | n/a | chr6:58225293-58225304 |
32 | MEF2A | chr6:58225134-58225601 | GM12878 | blood: | n/a | chr6:58225293-58225304 |
33 | MEF2A | chr6:58226980-58227298 | GM12878 | blood: | n/a | n/a |
34 | MEF2C | chr6:58225222-58225708 | GM12878 | blood: | n/a | chr6:58225293-58225304 |
35 | NFIC | chr6:58241531-58241991 | GM12878 | blood: | n/a | n/a |
36 | NFIC | chr6:58226950-58227444 | GM12878 | blood: | n/a | n/a |
37 | NFIC | chr6:58226805-58227569 | GM12878 | blood: | n/a | n/a |
38 | NFIC | chr6:58225020-58225878 | GM12878 | blood: | n/a | n/a |
39 | PBX3 | chr6:58227408-58227563 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr6:58226261-58226490 | ProgFib | skin: | n/a | n/a |
41 | POLR2A | chr6:58223451-58223478 | ProgFib | skin: | n/a | n/a |
42 | POU2F2 | chr6:58227056-58227217 | GM12878 | blood: | n/a | n/a |
43 | POU2F2 | chr6:58220377-58220736 | GM12878 | blood: | n/a | n/a |
44 | POU2F2 | chr6:58224989-58225663 | GM12878 | blood: | n/a | chr6:58225393-58225402 chr6:58225391-58225404 chr6:58225168-58225179 chr6:58225393-58225403 chr6:58225392-58225404 chr6:58225393-58225403 chr6:58225292-58225303 chr6:58225394-58225401 chr6:58225392-58225402 chr6:58225390-58225404 |
45 | POU2F2 | chr6:58227008-58227342 | GM12878 | blood: | n/a | chr6:58227268-58227279 chr6:58227270-58227278 chr6:58227267-58227282 chr6:58227263-58227284 chr6:58227263-58227285 |
46 | POU2F2 | chr6:58225297-58225485 | GM12878 | blood: | n/a | chr6:58225393-58225402 chr6:58225391-58225404 chr6:58225393-58225403 chr6:58225392-58225404 chr6:58225393-58225403 chr6:58225394-58225401 chr6:58225392-58225402 chr6:58225390-58225404 |
47 | POU2F2 | chr6:58225261-58225510 | GM12878 | blood: | n/a | chr6:58225393-58225402 chr6:58225391-58225404 chr6:58225393-58225403 chr6:58225392-58225404 chr6:58225393-58225403 chr6:58225292-58225303 chr6:58225394-58225401 chr6:58225392-58225402 chr6:58225390-58225404 |
48 | RUNX3 | chr6:58226962-58227377 | GM12878 | blood: | n/a | n/a |
49 | RUNX3 | chr6:58227046-58227284 | GM12878 | blood: | n/a | n/a |
50 | RUNX3 | chr6:58225034-58225584 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RAB23-3 | chr6:58234838-58240189 | ENSG00000272316.1 |
2 | lnc-RAB23-3 | chr6:58234692-58238642 | XLOC_005753 |
3 | lnc-RAB23-18 | chr6:58228887-58229426 | ENSG00000271761.1 |
4 | lnc-RAB23-3 | chr6:58239194-58239687 | XLOC_005753 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272316 | TF binding region |
ENSG00000271761 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570466791 | chr6:58226409-58226410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192445689 | chr6:58226440-58226441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552983550 | chr6:58226492-58226493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574605464 | chr6:58226585-58226586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542405545 | chr6:58226604-58226605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184997776 | chr6:58226605-58226606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576007669 | chr6:58226614-58226615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546518710 | chr6:58226618-58226619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564637356 | chr6:58226643-58226644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563792240 | chr6:58226850-58226851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548419585 | chr6:58226901-58226902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577372643 | chr6:58226998-58226999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541768695 | chr6:58227006-58227007 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540290488 | chr6:58227043-58227044 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188926505 | chr6:58227048-58227049 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2982029 | chr6:58227062-58227063 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529382128 | chr6:58227151-58227152 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2475577 | chr6:58227216-58227217 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547959592 | chr6:58227363-58227364 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559928178 | chr6:58227392-58227393 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569559789 | chr6:58227429-58227430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6926125 | chr6:58227450-58227451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs552407640 | chr6:58227455-58227456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570656566 | chr6:58227459-58227460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377143282 | chr6:58227517-58227518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552708684 | chr6:58227562-58227563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568143685 | chr6:58227609-58227610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535594463 | chr6:58227673-58227674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557581241 | chr6:58227680-58227681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575870299 | chr6:58227697-58227698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546087132 | chr6:58227703-58227704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2758421 | chr6:58227715-58227716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12662930 | chr6:58227724-58227725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2472997 | chr6:58227747-58227748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2475578 | chr6:58227790-58227791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183977765 | chr6:58227794-58227795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2758422 | chr6:58227809-58227810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3996679 | chr6:58227893-58227894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374820902 | chr6:58227913-58227914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs3996680 | chr6:58227954-58227955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs3996681 | chr6:58227968-58227969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529343082 | chr6:58227969-58227970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530777976 | chr6:58227970-58227971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544340120 | chr6:58228060-58228061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562651654 | chr6:58228078-58228079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530681894 | chr6:58228089-58228090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367838057 | chr6:58228106-58228107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552105833 | chr6:58228114-58228115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs477994 | chr6:58228129-58228130 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs189550523 | chr6:58228178-58228179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:58226400-58228200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr6:58226800-58227000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr6:58227000-58227400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr6:58237800-58245200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr6:58237800-58253400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr6:58238000-58245000 | Weak transcription | Fetal Stomach | stomach |
7 | chr6:58238000-58252600 | Weak transcription | Primary T cells fromperipheralblood | blood |
8 | chr6:58238000-58252800 | Weak transcription | Fetal Intestine Large | intestine |
9 | chr6:58240800-58245800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr6:58243000-58250200 | Weak transcription | Liver | Liver |
11 | chr6:58243000-58272800 | Weak transcription | Fetal Intestine Small | intestine |